Soluble glucan is internalized and trafficked to the golgi apparatus in macrophages via a clathrin-mediated, lipid raft-regulated mechanism

Journal of Pharmacology and Experimental Therapeutics

Volumn 342, Issue 3, 2012, Pages 808-815

  Ozment, Tammy R ^a   Goldman, Matthew P ^b   Kalbfleisch, John H ^a   Williams, David L ^a  

^a East Tennessee State University   (United States)

^b WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAVEOLIN 1; CLATHRIN; DECTIN 1; GLUCAN;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; ENDOSOME; GOLGI COMPLEX; INTERNALIZATION; LIPID RAFT; LYSOSOME; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; REGULATORY MECHANISM;

ANIMALS; CLATHRIN; ENDOSOMES; GLUCANS; GOLGI APPARATUS; LECTINS, C-TYPE; LIPIDS; LYSOSOMES; MACROPHAGES; MALE; MICE; MICE, INBRED ICR; MICE, KNOCKOUT; PROTEIN TRANSPORT;

EID: 84865182083     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.112.196329     Document Type: Article

References (41)

1. Aarsaether E, Rydningen M, Einar Engstad R, and Busund R (2006) Cardioprotective effect of pretreatment with β-glucan in coronary artery bypass grafting. Scand Cardiovasc J 40:298-304. (Pubitemid 44501939)
2. Ariizumi K, Shen GL, Shikano S, Xu S, Ritter R 3rd, Kumamoto T, Edelbaum D, Morita A, Bergstresser PR, and Takashima A (2000) Identification of a novel, dendritic cell-associated molecule, dectin-1, by subtractive cDNA cloning. J Biol Chem 275:20157-20167. (Pubitemid 30441627)
3. Bodey GP (2000) Fungal infections in immunocompromised patients-candidiasis. Infect Dis Rev 1:4-8.
4. Brown GD and Gordon S (2001) Immune recognition: A new receptor for β-glucans. Nature 413:36-37. (Pubitemid 32843478)
5. Brown GD, Herre J, Williams DL, Willment JA, Marshall AS, and Gordon S (2003) Dectin-1 mediates the biological effects of β-glucans. J Exp Med 197:1119-1124. (Pubitemid 36570067)
6. Brown GD, Taylor PR, Reid DM, Willment JA, Williams DL, Martinez-Pomares L, Wong SY, and Gordon S (2002) Dectin-1 is a major β-glucan receptor on macrophages. J Exp Med 196:407-412. (Pubitemid 34875669)
7. Digby J, Kalbfleisch J, Glenn A, Larsen A, Browder W, and Williams D (2003) Serum glucan levels are not specific for presence of fungal infections in intensive care unit patients. Clin Diagn Lab Immunol 10:882-885. (Pubitemid 37129504)
8. Ensley HE, Tobias B, Pretus HA, McNamee RB, Jones EL, Browder IW, and Williams DL (1994) NMR spectral analysis of a water-insoluble (1→3)-β-D-glucan isolated from Saccharomyces cerevisiae. Carbohydr Res 258:307-311. (Pubitemid 24161748)
9. Gantner BN, Simmons RM, Canavera SJ, Akira S, and Underhill DM (2003) Collaborative induction of inflammatory responses by dectin-1 and Toll-like receptor 2. J Exp Med 197:1107-1117. (Pubitemid 36570066)
10. Gross O, Gewies A, Finger K, Schäfer M, Sparwasser T, Peschel C, Förster I, and Ruland J (2006) Card9 controls a non-TLR signalling pathway for innate antifungal immunity. Nature 442:651-656. (Pubitemid 44215314)
11. Hernanz-Falcón P, Joffre O, Williams DL, and Reis e Sousa C (2009) Internalization of Dectin-1 terminates induction of inflammatory responses. Eur J Immunol 39:507-513.
12. Herre J, Marshall AS, Caron E, Edwards AD, Williams DL, Schweighoffer E, Tybulewicz V, Reis e Sousa C, Gordon S, and Brown GD (2004) Dectin-1 uses novel mechanisms for yeast phagocytosis in macrophages. Blood 104:4038-4045. (Pubitemid 39620154)
13. Hiyoshi M, Tagawa S, Hashimoto S, Sakamoto C, and Tatsumi N (1999) Evaluation of a new laboratory test measuring plasma (1→3)-β-D-glucan in the diagnosis of Candida deep mycosis: comparison with a serologic test. Kansenshogaku Zasshi 73:1-6.
14. Hong F, Yan J, Baran JT, Allendorf DJ, Hansen RD, Ostroff GR, Xing PX, Cheung NK, and Ross GD (2004) Mechanism by which orally administered β-1,3-glucans enhance the tumoricidal activity of antitumor monoclonal antibodies in murine tumor models. J Immunol 173:797-806. (Pubitemid 38924254)
15. Jayanthi LD, Samuvel DJ, and Ramamoorthy S (2004) Regulated internalization and phosphorylation of the native norepinephrine transporter in response to phorbol esters. Evidence for localization in lipid rafts and lipid raft-mediated internalization.J Biol Chem 279:19315-19326. (Pubitemid 38623363)
16. Latz E, Visintin A, Lien E, Fitzgerald KA, Monks BG, Kurt-Jones EA, Golenbock DT, and Espevik T (2002) Lipopolysaccharide rapidly traffics to and from the Golgi apparatus with the Toll-like receptor 4-MD-2-CD14 complex in a process that is distinct from the initiation of signal transduction. J Biol Chem 277:47834-47843. (Pubitemid 36159310)
17. Le PU and Nabi IR (2003) Distinct caveolae-mediated endocytic pathways target the Golgi apparatus and the endoplasmic reticulum. J Cell Sci 116:1059-1071. (Pubitemid 36395616)
18. Le Roy C and Wrana JL (2005) Clathrin- and non-clathrin-mediated endocytic regulation of cell signalling. Nat Rev Mol Cell Biol 6:112-126. (Pubitemid 40215807)
19. Li C, Ha T, Kelley J, Gao X, Qiu Y, Kao RL, Browder W, and Williams DL (2004) Modulating Toll-like receptor mediated signaling by (1→3)-β-D- glucan rapidly induces cardioprotection. Cardiovasc Res 61:538-547. (Pubitemid 38210159)
20. Lowman D, Ensley H, and Williams D (1998) Identification of phosphate substitution sites by NMR spectroscopy in a water-soluble phosphorylated (1-3)-β-D-glucan. Carbohydr Res 306:559-562. (Pubitemid 28318107)
21. McCann F, Carmona E, Puri V, Pagano RE, and Limper AH (2005) Macrophage internalization of fungal β-glucans is not necessary for initiation of related inflammatory responses. Infect Immun 73:6340-6349. (Pubitemid 41368795)
22. Mori T, Ikemoto H, Matsumura M, Yoshida M, Inada K, Endo S, Ito A, Watanabe S, Yamaguchi H, Mitsuya M, et al. (1997) Evaluation of plasma (1→3)-β-D-glucan measurement by the kinetic turbidimetric Limulus test, for the clinical diagnosis of mycotic infections. Eur J Clin Chem Clin Biochem 35:553-560.
23. Müller A, Mayberry W, Acuff R, Thedford S, Browder W, and Williams D (1994) Lipid content of macroparticulate (1→3)-β-D-glucan isolated from Saccharomyces cerevisiae. Microbios 79:253-261.
24. Müller A, Pretus HA, McNamee RB, Jones EL, Browder IW, and Williams DL (1995) Comparison of the carbohydrate biological response modifiers Krestin, schizophyllan and glucan phosphate by aqueous size exclusion chromatography with in-line argon-ion multi-angle laser light scattering photometry and differential viscometry detectors. J Chromatogr B Biomed Appl 666:283-290.
25. Nakamura Y, Tazawa S, and Tsutiya M (1998) The Clinical significance of plasma (1→3)-β-D-glucan measurement by the kinetic turbidimetric limulus test for fungal febrile episodes. Rinsho Biseibutshu Jinsoku Shindan Kenkyukai Shi 9:33-39.
26. Norkin LC (2001) Caveolae in the uptake and targeting of infectious agents and secreted toxins. Adv Drug Deliv Rev 49:301-315.
27. Ozment-Skelton TR, Goldman MP, Gordon S, Brown GD, and Williams DL (2006) Prolonged reduction of leukocyte membrane-associated Dectin-1 levels following β-glucan administration. J Pharmacol Exp Ther 318:540-546.
28. Rice PJ, Adams EL, Ozment-Skelton T, Gonzalez AJ, Goldman MP, Lockhart BE, Barker LA, Breuel KF, Deponti WK, Kalbfleisch JH, et al. (2005) Oral delivery and gastrointestinal absorption of soluble glucans stimulate increased resistance to infectious challenge. J Pharmacol Exp Ther 314:1079-1086. (Pubitemid 41205971)
29. Rice PJ, Lockhart BE, Barker LA, Adams EL, Ensley HE, and Williams DL (2004) Pharmacokinetics of fungal (1-3)-β-D-glucans following intravenous administration in rats. Int Immunopharmacol 4:1209-1215. (Pubitemid 38900857)
30. Rogers NC, Slack EC, Edwards AD, Nolte MA, Schulz O, Schweighoffer E, Williams DL, Gordon S, Tybulewicz VL, Brown GD, et al. (2005) Syk-dependent cytokine induction by Dectin-1 reveals a novel pattern recognition pathway for C type lectins. Immunity 22:507-517. (Pubitemid 40545115)
31. Rosas M, Liddiard K, Kimberg M, Faro-Trindade I, McDonald JU, Williams DL, Brown GD, and Taylor PR (2008) The induction of inflammation by dectin-1 in vivo is dependent on myeloid cell programming and the progression of phagocytosis. J Immunol 181:3549-3557.
32. Stone BA and Clarke AE (1992) Chemistry and Biology of (1-3)-β-D-Glucan. La Trobe University Press, Melbourne, Australia.
33. Taylor PR, Brown GD, Reid DM, Willment JA, Martinez-Pomares L, Gordon S, and Wong SY (2002) The β-glucan receptor, dectin-1, is predominantly expressed on the surface of cells of the monocyte/macrophage and neutrophil lineages. J Immunol 169:3876-3882.
34. Thieblemont N and Wright SD (1999) Transport of bacterial lipopolysaccharide to the Golgi apparatus. J Exp Med 190:523-534. (Pubitemid 29395380)
35. Triantafilou M, Manukyan M, Mackie A, Morath S, Hartung T, Heine H, and Triantafilou K (2004) Lipoteichoic acid and Toll-like receptor 2 internalization and targeting to the Golgi are lipid raft-dependent. J Biol Chem 279:40882-40889. (Pubitemid 39287687)
36. Underhill DM, Rossnagle E, Lowell CA, and Simmons RM (2005) Dectin-1 activates Syk tyrosine kinase in a dynamic subset of macrophages for reactive oxygen production. Blood 106:2543-2550. (Pubitemid 41510832)
37. Wei D, Zhang L, Williams DL, and Browder IW (2002) Glucan stimulates human dermal fibroblast collagen biosynthesis through a nuclear factor-1 dependent mechanism. Wound Repair Regen 10:161-168. (Pubitemid 34760894)
38. Williams DL (1997) Overview of (1→3)-β-D-glucan immunobiology. Mediators Inflamm 6:247-250.
39. Williams DL, McNamee RB, Jones EL, Pretus HA, Ensley HE, Browder IW, and Di Luzio NR (1991) A method for the solubilization of a (1-3)-β-D-glucan isolated from Saccharomyces cerevisiae. Carbohydr Res 219:203-213.
40. Williams DL, Mueller A, and Browder W (1996) Glucan-based macrophage stimulators: a review of their anti-infective potential. Clin Immunother 5:392-399.
41. Williams TM and Lisanti MP (2004) The Caveolin genes: from cell biology to medicine. Ann Med 36:584-595. (Pubitemid 40051435)